AMLX - Amylyx Pharmaceuticals Inc Dividends

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: INDV ALKS KNSA LNTH TLX NBIX BMRN AXSM INCY VRTX

| Held by: VTI IWM IWO VXF IBB XPH SCHA VTWO DFMC IHE

Scroll to Statements

Index	RUT
Market Cap	2.02B
Enterprise Value	1.75B
Income	-150.11M
Sales	0.00M
Book/sh	2.46
Cash/sh	2.52
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	136
IPO	Jan 07, 2022

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	7.39
P/C	7.22
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	17.85
Current Ratio	17.85
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	Yes / Yes

EPS (ttm)	-1.51
EPS next Y	-1.26
EPS next Q	-0.35
EPS this Y	7.85%
EPS next Y	10.32%
EPS next 5Y	26.18%
EPS past 3/5Y	19.94% -15.37%
Sales past 3/5Y	- -
EPS Y/Y TTM	51.42%
Sales Y/Y TTM	-100.00%
EPS Q/Q	10.88%
Sales Q/Q	-
Earnings	May 07 BMO
EPS/Sales Surpr.	-9.50% -

Insider Own	16.62%
Insider Trans	-2.18%
Inst Own	96.20%
Inst Trans	1.17%
ROA	-58.49%
ROE	-63.26%
ROIC	-54.07%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	12.31%
SMA50	19.13%
SMA200	26.07%
Trades

Shs Outstand	111.03M
Shs Float	92.71M
Short Float	14.15%
Short Ratio	9.63
Short Interest	13.12M
52W High	19.15 -5.12%
52W Low	6.14 196.17%
Volatility	5.61% 6.65%
ATR (14)	0.99
RSI (14)	67.74
Beta	-0.19
Rel Volume	1.11
Avg Volume	1.36M
Volume	1,517,018

Perf Week	-2.83%
Perf Month	26.97%
Perf Quarter	14.85%
Perf Half Y	59.11%
Perf YTD	50.41%
Perf Year	168.79%
Perf 3Y	-10.80%
Perf 5Y	-
Perf 10Y	-
Recom	1.09
Target Price	24.40
Prev Close	17.97
Price	18.17
Change	1.11%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)